Subsequent quantitative reverse transcription PCR (qRT-PCR) analysis verified that silencing of BTF3 resulted in decreased expression of individual RFC genes in prostate cancer (PC-3 and DU145) and 293 T cells (Fig. 4b). This evidence concerns the gene RFC1 and prostate carcinoma.